TWM
ABBV icon

TRB Wealth Management’s AbbVie ABBV Stock Holding History

TRB Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Sell
7,827
-5,019
-39% -$1.08M 0.26% 54
2026
Q1 		$2.79M Buy
+12,846
New +$2.85M 0.4% 48

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

TRB Wealth Management's ABBV Position: Q2 2026 in Review

TRB Wealth Management reduced its AbbVie (ABBV) stake by 39% in Q2 2026, selling an estimated $1.08M and leaving 7,827 shares worth $1.97M. The position accounts for 0.26% of the portfolio, ranked #54.

TRB Wealth Management first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.79M in Q1 2026. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • TRB Wealth Management held 7,827 shares of AbbVie worth $1.97M as of Q2 2026.
  • TRB Wealth Management sold 5,019 AbbVie shares in Q2 2026, an estimated $1.08M.
  • AbbVie made up 0.26% of TRB Wealth Management's portfolio in Q2 2026, its #54 holding.
  • TRB Wealth Management first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
  • TRB Wealth Management's AbbVie position peaked at $2.79M in Q1 2026.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TRB Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.